Ratings by Oppenheimer
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Jay Olson | Immuneering Corporation | IMRX | Maintain | Outperform (N/A) |
30.00 (N/A) |
|
Details | |
| 3/6/2026 | Matt Biegler | Day One Biopharmaceuticals | DAWN | Maintain | Perform (N/A) |
N/A (N/A) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 14,034 more... | |||||||||
